Development of a small chemical drug that targets EPHB1 for the treatment of chronic pain
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2110949
- Recipient
-
The University Of Texas Southwestern Medical Center UEI YZJ6DKPM4W63
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $1,460,103
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Dallas, TX 75390, USA
Award details come from USAspending.gov.
About this award
The University of Texas Southwestern Medical Center received a $1.46 million Project Grant award from the Department of the Army Medical Command to develop a small chemical drug targeting EphB1 for the treatment of chronic pain. The grant was awarded on September 30, 2021 with a completion date of September 29, 2024. The funding supports the Military Medical Research and Development program (CFDA 12.420), which aims to transform military and public health care through innovative biomedical research solutions for battlefield medicine. Under this award, the Medical Center will conduct research to investigate a medical solution for chronic pain by developing a targeted chemical compound to address the EphB1 protein pathway, with the goal of delivering an alternative drug therapy for chronic pain patients.
Quick answers
Who received award W81XWH2110949?
W81XWH2110949 was awarded to The University Of Texas Southwestern Medical Center by Medical Command (Department of the Army) on September 30, 2021.
How much is award W81XWH2110949 worth?
$1,460,103 has been obligated on W81XWH2110949.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award